S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
Log in
(Ad)
If you're happy with stocks yielding you 4% or 5% a year, you don't need this. But if you want to see how we built a portfolio that now pays us a 67% cash on cash return - with no leverage, options, or gimmicks.

NYSE:EVH - Evolent Health Stock Price, Forecast & News

$11.38
+0.32 (+2.89 %)
(As of 01/20/2020 02:53 PM ET)
Add
Compare
Today's Range
$10.65
Now: $11.38▼
$11.44
50-Day Range
$6.48
MA: $8.52▼
$11.38
52-Week Range
$5.50
Now: $11.38▼
$19.13
Volume1.45 million shs
Average Volume1.41 million shs
Market Capitalization$962.86 million
P/E RatioN/A
Dividend YieldN/A
Beta1.11
Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Read More…

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Management services
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNYSE:EVH
Previous Symbol
CUSIPN/A
CIK1628908
Webhttp://www.evolenthealth.com/
Phone571-389-6000

Debt

Debt-to-Equity Ratio0.27
Current Ratio1.19
Quick Ratio1.19

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$627.06 million
Price / Sales1.54
Cash Flow$0.28 per share
Price / Cash Flow41.31
Book Value$14.44 per share
Price / Book0.79

Profitability

EPS (Most Recent Fiscal Year)($0.35)
Net Income$-52,660,000.00
Net Margins-15.02%
Return on Equity-6.93%
Return on Assets-4.75%

Miscellaneous

Employees3,800
Outstanding Shares84,610,000
Market Cap$962.86 million
Next Earnings Date2/25/2020 (Estimated)
OptionableOptionable

Receive EVH News and Ratings via Email

Sign-up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.

EVH Rates by TradingView

(Ad)


In my 40+ year career, I have yet to see a convergence of three significant factors that has me this optimistic about the stock market. I believe 2020 could deliver the largest wealth-building opportunity in a generation. Don't miss out on this historic year.

Evolent Health (NYSE:EVH) Frequently Asked Questions

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

How were Evolent Health's earnings last quarter?

Evolent Health Inc (NYSE:EVH) posted its earnings results on Tuesday, November, 5th. The technology company reported ($0.09) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.12) by $0.03. The technology company earned $220.14 million during the quarter, compared to analyst estimates of $217.90 million. Evolent Health had a negative return on equity of 6.93% and a negative net margin of 15.02%. The company's quarterly revenue was up 46.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.04) EPS. View Evolent Health's Earnings History.

When is Evolent Health's next earnings date?

Evolent Health is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Evolent Health.

What price target have analysts set for EVH?

7 brokers have issued twelve-month price targets for Evolent Health's shares. Their forecasts range from $10.00 to $18.00. On average, they expect Evolent Health's stock price to reach $13.45 in the next year. This suggests a possible upside of 18.2% from the stock's current price. View Analyst Price Targets for Evolent Health.

What is the consensus analysts' recommendation for Evolent Health?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evolent Health.

Has Evolent Health been receiving favorable news coverage?

Headlines about EVH stock have trended somewhat positive this week, according to InfoTrie. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Evolent Health earned a news impact score of 1.7 on InfoTrie's scale. They also assigned media stories about the technology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Evolent Health.

Who are some of Evolent Health's key competitors?

Some companies that are related to Evolent Health include Mantech International (MANT), R1 RCM (RCM), Franklin Covey (FC), Jupai (JP), PHI Group (PHIL) and Rainmaker Systems (VCTL).

What other stocks do shareholders of Evolent Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Energy Transfer LP Unit (ET), Advanced Micro Devices (AMD), Transocean (RIG) and NVIDIA (NVDA).

Who are Evolent Health's key executives?

Evolent Health's management team includes the folowing people:
  • Mr. Frank J. Williams, Co-Founder, CEO & Chairman (Age 52)
  • Mr. Seth Blackley, Co-Founder, Pres & Director (Age 40)
  • Mr. Thomas Peterson III, Co-Founder & COO (Age 49)
  • Mr. Nicholas McGrane, Chief Financial Officer (Age 51)
  • Ms. Lydia Stone, VP, Chief Accounting Officer & Controller (Age 43)

When did Evolent Health IPO?

(EVH) raised $150 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (3.42%) and Peregrine Capital Management LLC (1.41%). Company insiders that own Evolent Health stock include Cheryl Scott, Doug S Aron, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Lydia Stone, Michael D'amato, Seth Blackley, Thomas Peterson III and Unitedhealth Group Inc. View Institutional Ownership Trends for Evolent Health.

Which institutional investors are selling Evolent Health stock?

EVH stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC and Peregrine Capital Management LLC. View Insider Buying and Selling for Evolent Health.

How do I buy shares of Evolent Health?

Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $11.38.

How big of a company is Evolent Health?

Evolent Health has a market capitalization of $962.86 million and generates $627.06 million in revenue each year. The technology company earns $-52,660,000.00 in net income (profit) each year or ($0.35) on an earnings per share basis. Evolent Health employs 3,800 workers across the globe.View Additional Information About Evolent Health.

What is Evolent Health's official website?

The official website for Evolent Health is http://www.evolenthealth.com/.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000.


MarketBeat Community Rating for Evolent Health (NYSE EVH)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  461 (Vote Outperform)
Underperform Votes:  272 (Vote Underperform)
Total Votes:  733
MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe EVH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Featured Article: Why does a company issue an IPO?
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel